Targeting metalloenzymes for therapeutic intervention

AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …

The structural biology of HIV-1: mechanistic and therapeutic insights

A Engelman, P Cherepanov - Nature Reviews Microbiology, 2012 - nature.com
Three-dimensional molecular structures can provide detailed information on biological
mechanisms and, for cases in which the molecular function affects human health, can …

Structure and function of retroviral integrase

GN Maertens, AN Engelman… - Nature Reviews …, 2022 - nature.com
A hallmark of retroviral replication is establishment of the proviral state, wherein a DNA copy
of the viral RNA genome is stably incorporated into a host cell chromosome. Integrase is the …

Clinical pharmacokinetic, pharmacodynamic and drug-interaction profile of the integrase inhibitor dolutegravir

ML Cottrell, T Hadzic, ADM Kashuba - Clinical pharmacokinetics, 2013 - Springer
Dolutegravir is a second-generation integrase strand transfer inhibitor (INSTI) currently
under review by the US Food and Drug Administration for marketing approval. The in vitro …

Retroviral DNA integration

P Lesbats, AN Engelman, P Cherepanov - Chemical reviews, 2016 - ACS Publications
The integration of a DNA copy of the viral RNA genome into host chromatin is the defining
step of retroviral replication. This enzymatic process is catalyzed by the virus-encoded …

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose …

J van Lunzen, F Maggiolo, JR Arribas… - The Lancet infectious …, 2012 - thelancet.com
Summary Background Dolutegravir (S/GSK1349572) is a new HIV-1 integrase inhibitor that
has antiviral activity with once daily, unboosted dosing. SPRING-1 is an ongoing study …

Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome

DO Passos, M Li, R Yang, SV Rebensburg… - Science, 2017 - science.org
Like all retroviruses, HIV-1 irreversibly inserts a viral DNA (vDNA) copy of its RNA genome
into host target DNA (tDNA). The intasome, a higher-order nucleoprotein complex composed …

Interfacial inhibitors: targeting macromolecular complexes

Y Pommier, C Marchand - Nature reviews Drug discovery, 2012 - nature.com
Interfacial inhibitors belong to a broad class of natural products and synthetic drugs that are
commonly used to treat cancers as well as bacterial and HIV infections. They bind …

Dolutegravir (S/GSK1349572) exhibits significantly slower dissociation than raltegravir and elvitegravir from wild-type and integrase inhibitor-resistant HIV-1 integrase …

KE Hightower, R Wang, F DeAnda… - Antimicrobial agents …, 2011 - Am Soc Microbiol
The integrase inhibitor (INI) dolutegravir (DTG; S/GSK1349572) has significant activity
against HIV-1 isolates with raltegravir (RAL)-and elvitegravir (ELV)-associated resistance …

Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S …

BA Johns, T Kawasuji, JG Weatherhead… - Journal of medicinal …, 2013 - ACS Publications
We report herein the discovery of the human immunodeficiency virus type-1 (HIV-1)
integrase inhibitors dolutegravir (S/GSK1349572)(3) and S/GSK1265744 (4). These drugs …